Insider · CIK 0001438946
Andreas Krebs
Files at DFTX (Definium Therapeutics, Inc.). First filing -, latest -.
Andreas Krebs files SEC Form 4 as director at DFTX (Definium Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andreas Krebs has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | DFTX Definium Therapeutics, Inc. | MOption exercise Common Shares | +1,629 | $35.52 | $58k | 21,402 | 25 d ago |
| Sep 18, 2026 | DFTX Definium Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -1,629 | $0.00 | $0 | 0 | 25 d ago |
| Jun 11, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Common Shares | +4,666 | $0.00 | $0 | 19,773 | Jun 15, 2026 |
| Jun 11, 2026 | DFTX Definium Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +19,188 | $0.00 | $0 | 19,188 | Jun 15, 2026 |
| Jun 12, 2025 | DFTX Definium Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,187 | $0.00 | $0 | 75,187 | Jun 16, 2025 |
Questions about Andreas Krebs
Answered from the filings on this page, as of the latest one.
Is Andreas Krebs buying or selling?
Andreas Krebs has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andreas Krebs's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andreas Krebs has 0.
Where does Andreas Krebs file Form 4?
Andreas Krebs has filed Form 4 at DFTX (Definium Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.